1[1]Sudoh T, Kangawa K, Minamino N,et al.A new natriuretic peptide in procine brain. Natur, 1988,332:78-81.
2[2]Hobbs RE. Using BNP to diagnose,manage and treat heart faliue. Cleve Clin J Med,2003,70:333-336.
3[3]Remme WJ, Swedberg K.Task force for the diagnosis and treatment of chronic heart failure, european society of cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J, 2001,22:1527-1560.
4[5]Cowie MW.BNP:Soon to become a routine measure in the care of patients with heart failure?Heart, 2000,83:617-618.
5[6]de Lemos JA,Morrow DA,Bentley JH,et al.The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. New Engl J Med, 2001,345:1014-1021.
6[7]Katayama T,Nakashima H,Yonekura T,et al.Clinical significance of acute phase brain natriuretic peptide in acute myocardial infarction treated with direct coronary angioplasty.J Cardiol, 2003,42:195-200.
7[9]Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation, 1995,92:1558-1564.
8[10]Mottram PM, Leano R, Marwick TH.Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function. Am J Cardiol,2003,92:1434-1438.
9[11]Kato J,Kitamura K,Uemura T, et al. Plasma levels of Adrenomedullin and atrial and Brain nariuretic peptides in the general population:their relation to age and pulse pressure. Hypertens Res, 2002,25:887-892.
10[12]Suzuki M, Yamamoto K, Watanabe S, et al. Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension. Am J Med,2000,108:627-633.
3Devereux RB, Reichek N. Echocardiographic determination of left ven- tricular mass in man:anatomic validation of the method[ J]. Circulation, 1977,55(4) :613-618.
5Felker GM,Petersen JW, Mark DB. Natriuretic peptides in the diagnosis and management of heart failure[J].C MAJ,2006,175 (4) :611-617.
6Maack T. The broad homeosmtie role of natriuredc peptides[J]. Am Bras Endocrinol Metab ,2006,50 ( 2 ) : 198-207.
7Scardovi AB, Coletta C, Aspromonte N, et al. Brain natriuretic peptide plasma level is a reliable indicator of advanced diastolic dysfunction in patients with chronic heart failure [ J ]. Eur J Echocardiogr, 2007,8 ( 1 ) : 30-36.
8Talwar S, Soebenhofer A, Williams B, et al. Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N-termininal pro BNP [J]. Heart, 2000, 83 ( 3 ) :278-287.
9Goetze JP, Christoffersen C,Perko M, et al. Increased cardiac BNP ex- pression associated with myocardial ischemia [ J]. FASEB J, 2003,17 (9) :1105-1107.
10Xu D, Patten RD, Force T. Gene 33/RALT is induced by hypoxia in car- diomyocytes,where it promotes cell death by suppressing phosphatidyli- nositol 3-kinase and extracellular signal-regulated kinase survival signa- ling[J].Mol Cell Biol,2006,26( 13 ) :5043-5054.
